The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
This strategic move aims to address the increasing global demand for biologics, enhancing ProBioGen's ability to support partners from cell line development t
The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise
DOVBLERON marks the 13th addition to Innovent’s commercial portfolio
MRX-5 is a novel benzoxazole antibiotic developed for the treatment of mycobacteria infections, particularly infections caused by non-tuberculous Mycobacteria
Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Subscribe To Our Newsletter & Stay Updated
